+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Multicenter study of patients treated with intravenous tPA for acute ischemic stroke The epidemiologic study of acute ischemic stroke

Multicenter study of patients treated with intravenous tPA for acute ischemic stroke The epidemiologic study of acute ischemic stroke

Neurology 58(7 Supplement 3): A337, April 9

(PDF emailed within 1 workday: $29.90)

Accession: 035349937

Download citation: RISBibTeXText

Related references

Recurrent Stroke, Myocardial Infarction, and Major Vascular Events during the First Year after Acute Ischemic Stroke: The Multicenter Prospective Observational Study about Recurrence and Its Determinants after Acute Ischemic Stroke I. Journal of Stroke and Cerebrovascular Diseases 25(3): 656-664, 2016

Clinical benefits of tenecteplase in acute ischemic stroke tenectaplase in ischemic stroke: A multicenter study form India. Journal of the Neurological Sciences 381: 144-145, 2017

Solitaireā„¢ with the Intention for Thrombectomy as Primary Endovascular Treatment for Acute Ischemic Stroke (SWIFT PRIME) trial: protocol for a randomized, controlled, multicenter study comparing the Solitaire revascularization device with IV tPA with IV tPA alone in acute ischemic stroke. International Journal of Stroke 10(3): 439-448, 2016

Risk for Major Bleeding in Patients Receiving Ticagrelor Compared With Aspirin After Transient Ischemic Attack or Acute Ischemic Stroke in the SOCRATES Study (Acute Stroke or Transient Ischemic Attack Treated With Aspirin or Ticagrelor and Patient Outcomes). Circulation 136(10): 907-916, 2017

The rtPA (alteplase) 0- to 6-hour acute stroke trial, part A (A0276g) : results of a double-blind, placebo-controlled, multicenter study. Thromblytic therapy in acute ischemic stroke study investigators. Stroke 31(4): 811-816, 2001

Low-molecular-weight heparin versus aspirin for acute ischemic stroke with large artery occlusive disease: subgroup analyses from the Fraxiparin in Stroke Study for the treatment of ischemic stroke (FISS-tris) study. Stroke 43(2): 346-349, 2012

Coronary Angiographic Findings in Acute Ischemic Stroke Patients With Elevated Cardiac Troponin: The Troponin Elevation in Acute Ischemic Stroke (TRELAS) Study. Circulation 133(13): 1264-1271, 2016

Cardiac Magnetic Resonance Imaging in Patients with Acute Ischemic Stroke and Elevated Troponin: A TRoponin ELevation in Acute Ischemic Stroke (TRELAS) Sub-Study. Cerebrovascular Diseases Extra 9(1): 19-24, 2019

Why do acute ischemic stroke patients with a preceding transient ischemic attack present with less severe strokes? Insights from the German Stroke Study. European Neurology 66(5): 265-270, 2012

Markers of increased risk of intracerebral hemorrhage after intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke in clinical practice: The multicenter rt-PA acute stroke survey. Circulation 105(14): 1679-1685, April 9, 2002

Safety and efficacy of non-vitamin K oral anticoagulant treatment compared with warfarin in patients with non-valvular atrial fibrillation who develop acute ischemic stroke or transient ischemic attack: a multicenter prospective cohort study (daVinci study). Journal of Thrombosis and Thrombolysis 42(4): 453-462, 2017

Prognostic factors in patients with acute ischemic stroke treated with intravenous tissue plasminogen activator: The first study among Iranian patients. Iranian Journal of Neurology 17(1): 31-37, 2018

A dose escalation safety study of intravenous tissue plasminogen activator in patients treated from 90 to 180 minutes from onset of acute ischemic stroke. Annals of Neurology 28(2): 225, 1990

A multicenter, randomized trial on neuroprotection with remote ischemic per-conditioning during acute ischemic stroke: the REmote iSchemic Conditioning in acUtE BRAin INfarction study protocol. International Journal of Stroke 11(8): 938-943, 2016

Neurological outcomes in patients with ischemic stroke receiving enoxaparin or heparin for venous thromboembolism prophylaxis: subanalysis of the Prevention of VTE after Acute Ischemic Stroke with LMWH (PREVAIL) study. Stroke 40(11): 3532-3540, 2009